932 related articles for article (PubMed ID: 11918752)
1. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients.
Mussap M; Dalla Vestra M; Fioretto P; Saller A; Varagnolo M; Nosadini R; Plebani M
Kidney Int; 2002 Apr; 61(4):1453-61. PubMed ID: 11918752
[TBL] [Abstract][Full Text] [Related]
2. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function.
Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
Nephrol Dial Transplant; 2006 Jul; 21(7):1855-62. PubMed ID: 16524933
[TBL] [Abstract][Full Text] [Related]
3. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.
Oddoze C; Morange S; Portugal H; Berland Y; Dussol B
Am J Kidney Dis; 2001 Aug; 38(2):310-6. PubMed ID: 11479157
[TBL] [Abstract][Full Text] [Related]
4. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate.
Hoek FJ; Kemperman FA; Krediet RT
Nephrol Dial Transplant; 2003 Oct; 18(10):2024-31. PubMed ID: 13679476
[TBL] [Abstract][Full Text] [Related]
5. Measurement of the kidney function in patients with rheumatoid arthritis: plasma cystatin C versus 51Cr-EDTA clearance.
Karstila K; Harmoinen AP; Lehtimäki TJ; Korpela MM; Mustonen JT; Saha HH
Nephron Clin Pract; 2008; 108(4):c284-90. PubMed ID: 18434750
[TBL] [Abstract][Full Text] [Related]
6. Interest of cystatin C in screening diabetic patients for early impairment of renal function.
Perlemoine C; Beauvieux MC; Rigalleau V; Baillet L; Barthes N; Derache P; Gin H
Metabolism; 2003 Oct; 52(10):1258-64. PubMed ID: 14564676
[TBL] [Abstract][Full Text] [Related]
7. Serum cystatin C-based equation compared to serum creatinine-based equations for estimation of glomerular filtration rate in patients with chronic kidney disease.
Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
Clin Nephrol; 2008 Jul; 70(1):10-7. PubMed ID: 18793543
[TBL] [Abstract][Full Text] [Related]
8. Serum cystatin C as an endogenous marker of renal function in the elderly.
Hojs R; Bevc S; Antolinc B; Gorenjak M; Puklavec L
Int J Clin Pharmacol Res; 2004; 24(2-3):49-54. PubMed ID: 15689051
[TBL] [Abstract][Full Text] [Related]
9. Cystatin C as a marker for glomerular filtration rate in pediatric patients.
Ylinen EA; Ala-Houhala M; Harmoinen AP; Knip M
Pediatr Nephrol; 1999 Aug; 13(6):506-9. PubMed ID: 10452279
[TBL] [Abstract][Full Text] [Related]
10. Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old.
Van Den Noortgate NJ; Janssens WH; Delanghe JR; Afschrift MB; Lameire NH
J Am Geriatr Soc; 2002 Jul; 50(7):1278-82. PubMed ID: 12133025
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of plasma cystatin C as a marker for glomerular filtration rate in patients with type 2 diabetes.
Harmoinen AP; Kouri TT; Wirta OR; Lehtimäki TJ; Rantalaiho V; Turjanmaa VM; Pasternack AI
Clin Nephrol; 1999 Dec; 52(6):363-70. PubMed ID: 10604644
[TBL] [Abstract][Full Text] [Related]
12. Creatinine clearance, Cockcroft-Gault formula and cystatin C: estimators of true glomerular filtration rate in the elderly?
Burkhardt H; Bojarsky G; Gretz N; Gladisch R
Gerontology; 2002; 48(3):140-6. PubMed ID: 11961366
[TBL] [Abstract][Full Text] [Related]
13. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
Christensson AG; Grubb AO; Nilsson JA; Norrgren K; Sterner G; Sundkvist G
J Intern Med; 2004 Dec; 256(6):510-8. PubMed ID: 15554952
[TBL] [Abstract][Full Text] [Related]
14. Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy.
Rossing P; Rossing K; Gaede P; Pedersen O; Parving HH
Diabetes Care; 2006 May; 29(5):1024-30. PubMed ID: 16644632
[TBL] [Abstract][Full Text] [Related]
15. Use of serum cystatin C to detect early decline of glomerular filtration rate in type 2 diabetes.
Yang YS; Peng CH; Lin CK; Wang CP; Huang CN
Intern Med; 2007; 46(12):801-6. PubMed ID: 17575370
[TBL] [Abstract][Full Text] [Related]
16. The accuracy of cystatin C and commonly used creatinine-based methods for detecting moderate and mild chronic kidney disease in diabetes.
Macisaac RJ; Tsalamandris C; Thomas MC; Premaratne E; Panagiotopoulos S; Smith TJ; Poon A; Jenkins MA; Ratnaike SI; Power DA; Jerums G
Diabet Med; 2007 Apr; 24(4):443-8. PubMed ID: 17388960
[TBL] [Abstract][Full Text] [Related]
17. Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes.
Rigalleau V; Beauvieux MC; Le Moigne F; Lasseur C; Chauveau P; Raffaitin C; Perlemoine C; Barthe N; Combe C; Gin H
Diabetes Metab; 2008 Nov; 34(5):482-9. PubMed ID: 18703370
[TBL] [Abstract][Full Text] [Related]
18. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
Hermida J; Tutor JC
Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
[TBL] [Abstract][Full Text] [Related]
19. A cystatin C-based formula without anthropometric variables estimates glomerular filtration rate better than creatinine clearance using the Cockcroft-Gault formula.
Grubb A; Björk J; Lindström V; Sterner G; Bondesson P; Nyman U
Scand J Clin Lab Invest; 2005; 65(2):153-62. PubMed ID: 16025838
[TBL] [Abstract][Full Text] [Related]
20. Cystatin C does not detect acute changes in glomerular filtration rate in early diabetic nephropathy.
Mueller TF; Raeder J; Oettl K; Zitta S; Klausmann G; Estelberger W; Luyckx VA; Reibnegger G
Ren Fail; 2008; 30(1):21-9. PubMed ID: 18197539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
